• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Baxter-sponsored study supports use of hemodynamic monitoring to help predict outcomes

Baxter-sponsored study supports use of hemodynamic monitoring to help predict outcomes

April 19, 2022 By Sean Whooley

BaxterBaxter (NYSE:BAX) announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes.

The Baxter-sponsored study found that monitoring stroke volume and cardiac output trends for patients with critical conditions may offer vital insight into cardiac function and aid in predicting patient outcomes, including mortality.

Deerfield, Illinois-based Baxter’s study findings were presented in an abstract titled “Stroke Volume Change Predicts Patient Outcome” at the Society of Critical Care Medicine (SCCM) Critical Care Congress taking place April 18-21, 2022, according to a news release.

The study evaluated trends in stroke volume and cardiac output over time as they relate to outcomes for 127 critically ill patients. The patients in the intensive care unit received hemodynamic monitoring with the Baxter Starling fluid management monitoring system.

Among the patient population, 64% had sepsis and 15% had COVID-19. Study investigators found that patients exhibiting an overall improvement in stroke volume showed a decrease in mortality (14.9) compared to those who did not improve overall stroke volume (35%).

The findings also indicated that closely monitoring cardiac function may be important in preventing clinically relevant changes in patient outcome, Baxter said in the release.

“These findings reinforce the importance of using non-invasive patient monitoring technology to deliver quick and precise fluid management data that can help clinicians make more informed, personalized treatment decisions and help enhance outcomes for critically ill patients,” Baxter VP of Meidcal Affairs Dr. Douglas M. Hansell said. “Baxter plans to continue assessing data from the Starling registry to examine the role of hemodynamic monitoring across a variety of clinical settings and patient diagnoses.”

Filed Under: Blood Management, Cardiovascular, Clinical Trials, Featured, Neurological, News Well, Patient Monitoring Tagged With: Baxter

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy